Literature DB >> 11324968

Specific absorbed fractions from the image-based VIP-Man body model and EGS4-VLSI Monte Carlo code: internal electron emitters.

T C Chao1, X G Xu.   

Abstract

VIP-Man is a whole-body anatomical model newly developed at Rensselaer from the high-resolution colour images of the National Library of Medicine's Visible Human Project. This paper summarizes the use of VIP-Man and the Monte Carlo method to calculate specific absorbed fractions from internal electron emitters. A specially designed EGS4 user code, named EGS4-VLSI, was developed to use the extremely large number of image data contained in the VIP-Man. Monoenergetic and isotropic electron emitters with energies from 100 keV to 4 MeV are considered to be uniformly distributed in 26 organs. This paper presents, for the first time, results of internal electron exposures based on a realistic whole-body tomographic model. Because VIP-Man has many organs and tissues that were previously not well defined (or not available) in other models, the efforts at Rensselaer and elsewhere bring an unprecedented opportunity to significantly improve the internal dosimetry.

Entities:  

Mesh:

Year:  2001        PMID: 11324968     DOI: 10.1088/0031-9155/46/4/301

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  10 in total

1.  SAF values for internal photon emitters calculated for the RPI-P pregnant-female models using Monte Carlo methods.

Authors:  C Y Shi; X George Xu; Michael G Stabin
Journal:  Med Phys       Date:  2008-07       Impact factor: 4.071

2.  Specific absorbed fractions for internal electron emitters derived for a set of anatomically realistic reference pregnant female models.

Authors:  Bingqi Guo; X George Xu; Chengyu Shi
Journal:  Radiat Prot Dosimetry       Date:  2009-09-18       Impact factor: 0.972

3.  S values for 131I based on the ICRP adult voxel phantoms.

Authors:  Stephanie Lamart; Steven L Simon; Andre Bouville; Brian E Moroz; Choonsik Lee
Journal:  Radiat Prot Dosimetry       Date:  2015-03-31       Impact factor: 0.972

4.  Advances in Computational Human Phantoms and Their Applications in Biomedical Engineering - A Topical Review.

Authors:  Wolfgang Kainz; Esra Neufeld; Wesley E Bolch; Christian G Graff; Chan Hyeong Kim; Niels Kuster; Bryn Lloyd; Tina Morrison; Paul Segars; Yeon Soo Yeom; Maria Zankl; X George Xu; Benjamin M W Tsui
Journal:  IEEE Trans Radiat Plasma Med Sci       Date:  2019-01

Review 5.  An exponential growth of computational phantom research in radiation protection, imaging, and radiotherapy: a review of the fifty-year history.

Authors:  X George Xu
Journal:  Phys Med Biol       Date:  2014-08-21       Impact factor: 3.609

6.  KOREAN PEDIATRIC AND ADULT HEAD COMPUTATIONAL PHANTOMS AND APPLICATION TO PHOTON SPECIFIC ABSORBED FRACTIONS CALCULATIONS.

Authors:  Daphnée Villoing; Dayton McMillan; Kwang Pyo Kim; Ae-Kyoung Lee; Hyung-do Choi; Choonsik Lee
Journal:  Radiat Prot Dosimetry       Date:  2017-11-01       Impact factor: 0.972

7.  Comparison of internal dosimetry factors for three classes of adult computational phantoms with emphasis on I-131 in the thyroid.

Authors:  Stephanie Lamart; Andre Bouville; Steven L Simon; Keith F Eckerman; Dunstana Melo; Choonsik Lee
Journal:  Phys Med Biol       Date:  2011-11-21       Impact factor: 3.609

Review 8.  Voxel-based computational models of real human anatomy: a review.

Authors:  Martin Caon
Journal:  Radiat Environ Biophys       Date:  2004-01-17       Impact factor: 1.925

9.  RADAR reference adult, pediatric, and pregnant female phantom series for internal and external dosimetry.

Authors:  Michael G Stabin; X George Xu; Mary A Emmons; W Paul Segars; Chengyu Shi; Michael J Fernald
Journal:  J Nucl Med       Date:  2012-09-11       Impact factor: 10.057

10.  Development of a geometry-based respiratory motion-simulating patient model for radiation treatment dosimetry.

Authors:  Juying Zhang; George X Xu; Chengyu Shi; Martin Fuss
Journal:  J Appl Clin Med Phys       Date:  2008-01-21       Impact factor: 2.102

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.